WAVE logo

Waverley Pharma Inc. Stock Price

TSXV:WAVE Community·CA$540.0k Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

WAVE Share Price Performance

CA$0.01
-0.00 (-33.33%)
CA$0.01
-0.00 (-33.33%)
Price CA$0.01

WAVE Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Medium-low risk and slightly overvalued.

6 Risks
0 Rewards

Waverley Pharma Inc. Key Details

CA$1.2m

Revenue

CA$780.4k

Cost of Revenue

CA$465.0k

Gross Profit

CA$1.1m

Other Expenses

-CA$628.6k

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-0.012
37.34%
-50.47%
-121.7%
View Full Analysis

About WAVE

Founded
2014
Employees
n/a
CEO
Larry Thiessen
WebsiteView website
www.waverleypharma.com

Waverley Pharma Inc., a biopharmaceutical company, researches, develops, and commercializes oncology therapeutics in the United Kingdom. The company develops PARP-1 Inhibitors for cancer treatment. It also operates a retail pharmacy in the United States. In addition, it is involved in the sale of prescription medications, over-the-counter products, and associated pharmacy services. Waverley Pharma Inc. was founded in 2014 and is headquartered in Winnipeg, Canada.

Recent WAVE News & Updates

Recent updates

No updates